Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 01-2010 | 10-2009 | 07-2009 | 04-2009 | 01-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 446 | 330 | 240 | 198 | 365 |
| Receivables | 22 | 42 | 91 | 37 | 42 |
| TOTAL | $478 | $372 | $331 | $245 | $411 |
| Non-Current Assets | |||||
| PPE Net | 2,921 | 2,957 | 2,920 | 2,974 | 2,979 |
| TOTAL | $2,921 | $2,957 | $2,920 | $2,974 | $2,979 |
| Total Assets | $3,398 | $3,329 | $3,250 | $3,220 | $3,390 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 801 | 789 | 13 | 70 | 3 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1 |
| TOTAL | $1,061 | $1,032 | $26 | $76 | $19 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 763 | 737 | 772 |
| TOTAL | $0 | $0 | $763 | $737 | $772 |
| Total Liabilities | $1,061 | $1,032 | $788 | $813 | $791 |
| Shareholders' Equity | |||||
| Common Shares | 12 | 11 | 11 | 24 | 24 |
| Retained earnings | -3,655 | -3,372 | -3,203 | -2,994 | -2,781 |
| TOTAL | $2,337 | $2,298 | $2,462 | $2,406 | $2,599 |
| Total Liabilities And Equity | $3,398 | $3,329 | $3,250 | $3,220 | $3,390 |